Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04663061 · ClinicalTrials.gov registry record · NA
Diabetes Data-Assisted Remission Trial (DDART)
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT04663061 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 64 participants.
The verdict
NCT04663061, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The study team will study the efficacy of a high intensity medical weight loss intervention paired with a digital platform to create weight loss and induce remission of type 2 diabetes mellitus (T2DM) compared to a diabetes self-management education intervention. The digital platform provides the capability to tailor the treatment plan, provide automated support, and alert providers when a participant may need more support from the clinical team. If shown to be efficacious, this research could be highly impactful, causing us to rethink our approach to care for those with T2DM and shift the paradigm for millions of individuals in the United States. Furthermore, this approach will demonstrate the feasibility of helping people engage in metabolic treatment strategies in a way that is scalable leveraging digital and mobile solutions that extend the patient-provider relationship, shift care from episodic approaches to more of an on-going model that extends into the life of the patient, while also integrated within the healthcare system workflows.
Interventions
- BEHAVIORAL Diabetes education
- BEHAVIORAL Medical weight loss
- BEHAVIORAL Continuous glucose monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2021-06-09 |
| Est. Completion | 2024-11-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04663061
The ClinicalTrials.gov registry entry for NCT04663061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Diabetes education is the first listed.
NCT04663061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04663061 about?
NCT04663061 is a clinical study titled "Diabetes Data-Assisted Remission Trial (DDART)". The study team will study the efficacy of a high intensity medical weight loss intervention paired with a digital platform to create weight loss and induce remission of type 2 diabetes mellitus (T2DM) compared to a diabetes self-management education intervention. The digital platform provides the ca...
What is the current status of trial NCT04663061?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2021-06-09. Estimated completion is 2024-11-14.
What interventions are being tested in trial NCT04663061?
The interventions under investigation include: Diabetes education (BEHAVIORAL), Medical weight loss (BEHAVIORAL), Continuous glucose monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT04663061?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.